STEMREGEN secures its third consecutive Inc. 5000 appearance, reporting a 1,017% three-year growth rate and a national ranking of No. 332 as it scales its stem cell supplement operations.
STEMREGEN was named to the Inc. 5000 for the third consecutive year, reflecting strong three-year growth of 1,017%.
STEMREGEN has been named to the Inc. 5000 list for the third consecutive year, driven by a robust 1,017% growth rate over the past three years. The supplement company, which focuses on supporting the body's innate stem cell repair system, currently holds the No. 332 position on the national rankings.
The ranking highlights the company's rapid expansion and sustained financial performance, specifically noting a 1,017% growth rate over the last three years.